10x Genomics, Inc. vs Nvidia Corp
TXG vs NVDA — side-by-side comparison from reported financials. TXG leads 1, NVDA leads 6 of 7 comparable metrics.
10x Genomics, Inc.
TXG · Technology
$81.05+4.88%Strained
Nvidia Corp
NVDA · Technology
$229.39-0.47%Mixed
| Metric | TXG | NVDA |
|---|---|---|
| Price | $81.05 | $229.39 |
| Market cap | $10.6B | $5.54T |
| Revenue (TTM) | $617M | $303B |
| Revenue growth | +7.6% | +100.0% |
| Net margin | -12.2% | 63.7% |
| Free cash flow | $121M | $127B |
| Net cash (debt) | — | $2.14B |
| 1-year price return | +592.1% | +19.1% |
| P/E | — | 28.6 |
| P/E vs own history (cheap-side %) | — | 96% |
| Dividend yield | — | 0.12% |
| Return on equity | -9% | 110% |
| CV checks passed | 4 of 9 | 10 of 9 |
| Employees | 1,178 | 42,000 |
Full résumé-style profiles: TXG CV · NVDA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.